免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

OsteoSight™ 髋关节 (v1)

K号: K251408 · 2025-09-02

决定日期2025-09-02
产品代码SAO
咨询委员会RA
决定实质等同

器械摘要

OsteoSight™ Hip (v1) is the device name listed in this FDA 510(k) record. The listed applicant is Naitive Technologies, Ltd.. It received FDA 510(k) clearance on 2025-09-02 under 510(k) number K251408. The device is classified under product code SAO. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the OsteoSight™ Hip (v1)?

OsteoSight™ Hip (v1) is a medical device that received FDA 510(k) clearance on 2025-09-02. The listed applicant is Naitive Technologies, Ltd.. The 510(k) number is K251408.

When did OsteoSight™ Hip (v1) receive FDA 510(k) clearance?

OsteoSight™ Hip (v1) received FDA 510(k) clearance on 2025-09-02, under 510(k) number K251408.

Who is the listed applicant for OsteoSight™ Hip (v1)?

The FDA 510(k) record lists Naitive Technologies, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for OsteoSight™ Hip (v1)?

The FDA product code for OsteoSight™ Hip (v1) is SAO.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:SAO)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑